Regulatory

NattoPharma is looking to harness its extensive body of research showing vitamin K2’s heart- and bone-health benefits, as well as establishing clinical biomarkers to demonstrate the consequences of vitamin K2 deficiency, with the hope of one day seeing the creation of a Recommended Daily Intake (RDI) value for K2.

In honor of Hemp History Week, Nutritional Outlook spoke with John Roulac, founder and chief visionary officer at plant-based organic foods company Nutiva, about the current regulatory landscape for U.S. industrial hemp farming, and what’s next for the hemp category.